Grantham, Mayo, Van Otterloo & Co (GMO)’s American Tower AMT Stock Holding History
Bought
Maintained
Sold
Other funds holding AMT
VCM
VPM
Grantham, Mayo, Van Otterloo & Co (GMO)'s AMT Position: Q1 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of American Tower (AMT) in Q1 2026, closing a stake of 6,412 shares — an estimated $1.13M sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in AMT in Q2 2013 and held it in 16 quarters. The position peaked at $14M in Q2 2013. 1,748 funds tracked by Wall St. Rank hold AMT as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining American Tower position as of Q1 2026 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 6,412 American Tower shares in Q1 2026, an estimated $1.13M.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in American Tower in Q2 2013 and held it in 16 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s American Tower position peaked at $14M in Q2 2013.
- 1,748 funds tracked by Wall St. Rank held American Tower as of Q1 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.